Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
FDA approves Johnson & Johnson’s nasal spray for depression
FDA Approves Nasal Spray for Depression
The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants.
FDA approves standalone use of J&J’s ketamine-derived depression treatment
The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used as a standalone treatment for patients with severe depression, the company said on Tuesday.
J&J's ketamine-derived nasal spray approved by FDA to treat depression
Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those who had an inadequate response to oral antidepressants.
FDA approves Spravato, first monotherapy nasal spray to treat depression
The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato was approved to treat a major depressive disorder,
US FDA approves J&J's ketamine-based therapy to treat depression
The U.S. Food and Drug Administration approved Johnson & Johnson's ketamine-based nasal spray Spravato to treat adults with major depressive disorder, the company said on Tuesday. The approval paves the way for use of Spravato in patients whose disease has stopped responding to at least two oral anti-depressants.
FDA allows standalone use of nasal spray antidepressant Spravato
The U.S. Food and Drug Administration has expanded its approval of Spravato, an antidepressant nasal spray. The drug is now cleared for use as a standalone treatment for depression.
Nose spray to treat depression? FDA approves first-of-its-kind medicine
The U.S. Food and Drug Administration has approved a nose spray to help treat depression, Johnson & Johnson announced Tuesday.
5m
Depression's indirect biological trigger: Study shows inflammation as the cause
A study shows a chain: low emotional clarity is linked to depression, and this clarity is influenced by higher inflammation ...
1d
on MSN
Blue Monday isn’t real, but seasonal depression affects millions of people. There are ways to treat it
Blue Monday originated from a publicity stunt, but seasonal affective disorder is a real affliction that affects millions of ...
23h
What's the Connection Between Weight & Depression?
Part of you is concerned — after all, you know depression can be serious — but on the other hand, can’t weight loss be a good ...
Psychology Today
3d
New Strategies for Treatment-Resistant Depression
Effective treatments for people with serious depression who have not been helped by antidepressant medications have novel ...
1d
on MSN
Inauguration Day in photos, the allure of coffee shops, how to handle seasonal depression: Catch up on the day’s stories
Inauguration Day in photos, the allure of coffee shops, how to handle seasonal depression: Catch up on the day’s stories ...
mic
1h
A Nasal Spray For Depression? FDA Gives Its Approval
The U.S. Food and Drug Administration (FDA) has approved Johnson & Johnson's nasal spray, Spravato (esketamine), as the first ...
17h
on MSN
Drawing a line from the gut microbiome to inflammation and depression
It's become increasingly clear that the gut microbiome can affect human health, including mental health. Which bacterial ...
Hosted on MSN
12m
Can Lexapro Cause Weight Loss? What to Know
If you’ve been diagnosed with major depressive disorder or a form of anxiety, your mental health provider may prescribe the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Popular topics
# Depression
# Great Depression
Related topics
United States
Spravato
Johnson & Johnson
Food and Drug Administration
Blue Monday
Feedback